Translation and validation of chinese version of MDASI immunotherapy for early-phase trials module: a cross-sectional study

BACKGROUND: During immunotherapy treatment and survival, identifying symptoms requires a standardized and validated assessment tool. The aim of this study was to translate, validate and use the Chinese version of the Immunotherapy of the M.D. Anderson Symptom Inventory for Early-Phase Trials module...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaodan, Xie, Jingyue, Lin, Xiumei, Hua, Limei, Ding, Peirong, Liu, Shuyue, Shi, Simei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201700/
https://www.ncbi.nlm.nih.gov/pubmed/37217922
http://dx.doi.org/10.1186/s12912-023-01217-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201700/
https://www.ncbi.nlm.nih.gov/pubmed/37217922
http://dx.doi.org/10.1186/s12912-023-01217-9

Ejemplares similares